SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Unquoted Biotechs
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bob zagorin who wrote (197)10/15/2007 1:40:04 AM
From: tuck   of 253
 
Why is this post even here? All of these biotechs are quoted, publicly traded in this country. I say throw it on the valuation thread.

I know the thread header doesn't explicitly say this, but really, it's for tracking certain interesting private companies. Have you read through a bit of it?

FWIW, since the post is in play . . . I own GTCB now, and a smidge of ZGEN (used to own more, & would buy more on even marginal weakness (i.e. if it drops a buck or so)), tempted by JAV (which is well followed on IHub}.

NTEC . . . can they really get around Amgen's IP with their formulation? I have no clue, just asking . . . though I'd guess that if Roche loses in court with Cera (which is PEGged with NKTR technology), NTEC also has little chance.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News